Cargando…

Nested Case‐Control Study Utilizing MID‐NET® on Thrombocytopenia Associated With Pegfilgrastim in Patients Treated With Antineoplastic Agents

Although several spontaneous case reports on the occurrence of thrombocytopenia in patients treated with human granulocyte colony‐stimulating factor (G‐CSF) preparations have been accumulated, its actual causality is still unclear. To investigate the association between G‐CSF preparations (filgrasti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kajiyama, Kazuhiro, Ishiguro, Chieko, Ando, Takashi, Kubota, Yuki, Kinoshita, Natsumi, Oniyama, Yukio, Iguchi, Toyotaka, Uyama, Yoshiaki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8359991/ https://www.ncbi.nlm.nih.gov/pubmed/33866559 http://dx.doi.org/10.1002/cpt.2263

Ejemplares similares

Effect of Hepatitis C Drugs on Blood Coagulability in Patients on Warfarin Using the Medical Information Database Network (MID-NET(®)) in Japan
por: Sawada, Sono, et al.
Publicado: (2021)

Cardiovascular risk of urate‐lowering drugs: A study using the National Database of Health Insurance Claims and Specific Health Checkups of Japan
por: Sawada, Sono, et al.
Publicado: (2022)

Use of National Database of Health Insurance Claims and Specific Health Checkups for examining practical utilization and safety signal of a drug to support regulatory assessment on postmarketing drug safety in Japan
por: Shida, Haruka, et al.
Publicado: (2023)

Assessing the Risk of Decrease in Kidney Function in Patients Prescribed Direct-Acting Antivirals for Hepatitis C Utilizing the MID-NET(®) Medical Information Database Network in Japan
por: Hasegawa, Tomoaki, et al.
Publicado: (2022)

Antineoplastics: Anaemia, thrombocytopenia and reduction in ejection fraction: case report
Publicado: (2021)

Updated report of COVID-19 vaccine safety monitoring in Japan: Booster shots and paediatric vaccinations
por: Yamaguchi, Toshihiro, et al.
Publicado: (2022)

Safety monitoring of COVID-19 vaccines in Japan
por: Yamaguchi, Toshihiro, et al.
Publicado: (2022)

Updated report of COVID-19 vaccine safety monitoring in Japan: booster doses for Omicron variants and vaccinations for infants and young children
por: Yamaguchi, Toshihiro, et al.
Publicado: (2023)

The Safety Profile of Filgrastim and Pegfilgrastim
por: Neumann, Theresa A., et al.
Publicado: (2011)

Cumulative Adverse Event Reporting of Anaphylaxis After mRNA COVID-19 Vaccine (Pfizer-BioNTech) Injections in Japan: The First-Month Report
por: Iguchi, Toyotaka, et al.
Publicado: (2021)

Pegfilgrastim Biosimilars: Where Are We Now?
por: Selby, Christopher, et al.
Publicado: (2021)

Pegfilgrastim in Supportive Care of Hodgkin Lymphoma
por: Cerchione, Claudio, et al.
Publicado: (2022)

Biosimilar Pegfilgrastim-cbqv Demonstrated Similar Immunogenicity to Pegfilgrastim in Healthy Subjects Across Three Randomized Clinical Studies
por: Civoli, Francesca, et al.
Publicado: (2022)

Relapsing Acute Kidney Injury Associated with Pegfilgrastim
por: Arora, Swati, et al.
Publicado: (2012)

The predictive model for risk of chemotherapy-induced thrombocytopenia based on antineoplastic drugs for solid tumors in eastern China
por: Zhou, Shishi, et al.
Publicado: (2023)

Efficacy and safety of two pegfilgrastim biosimilars: Tripegfilgrastim and pegteograstim
por: Kang, Ka‐Won, et al.
Publicado: (2020)

Pegfilgrastim for primary prophylaxis of febrile neutropenia in multiple myeloma
por: Cerchione, Claudio, et al.
Publicado: (2021)

Cyclophosphamide/docetaxel/pegfilgrastim: Various toxicities: case report
Publicado: (2021)

Evaluation of a novel medical device for pegfilgrastim administration
por: Aruga, Tomoyuki, et al.
Publicado: (2022)

Association of Immune Thrombocytopenia and Interstitial Pneumonia
por: Kushima, Hisako, et al.
Publicado: (2019)

Immunogenicity and safety of a proposed pegfilgrastim biosimilar MSB11455 versus the reference pegfilgrastim Neulasta(®) in healthy subjects: A randomized, double‐blind trial
por: Wynne, Chris, et al.
Publicado: (2020)

PB2416: EFFICACY AND SAFETY OF BIOSIMILAR PEGFILGRASTIM AFTER AUTOLOGOUS STEM CELL TRANSPLANT: A COMPARATIVE STUDY WITH BIOSIMILAR FILGRASTIM, LENOGRASTIM AND ORIGINATOR PEGFILGRASTIM
por: Marchesi, Francesco, et al.
Publicado: (2023)

Safety of Pegfilgrastim (Neulasta) in Patients with Sickle Cell Trait/Anemia
por: Kasi, Pashtoon Murtaza, et al.
Publicado: (2013)

Establishment of the MID‐NET(®) medical information database network as a reliable and valuable database for drug safety assessments in Japan
por: Yamaguchi, Mitsune, et al.
Publicado: (2019)

Pseudogout Attack after Pegfilgrastim Administration in Anaplastic Large Cell Lymphoma
por: Hatayama, Mayumi, et al.
Publicado: (2018)

Neutrophilic eccrine hidradenitis secondary to pegfilgrastim in a patient with synovial sarcoma
por: Puar, Neha, et al.
Publicado: (2019)

Pharmacodynamics, safety, and immunogenicity of Pelmeg(®), a pegfilgrastim biosimilar in healthy subjects
por: Wessels, Hendrik, et al.
Publicado: (2019)

Sensitivity of Pegfilgrastim Pharmacokinetic and Pharmacodynamic Parameters to Product Differences in Similarity Studies
por: Brekkan, Ari, et al.
Publicado: (2019)

Resistance to antineoplastic drugs
por: Twentyman, Peter
Publicado: (1990)

Early administration of pegfilgrastim for esophageal cancer treated with docetaxel, cisplatin, and fluorouracil: A phase II study
por: Ishikawa, Takeshi, et al.
Publicado: (2019)

Pharmacokinetics, pharmacodynamics, safety, and immunogenicity of Pelmeg(®), a pegfilgrastim biosimilar in healthy subjects
por: Roth, Karsten, et al.
Publicado: (2019)

Biosimilar Pegfilgrastim: Improving Access and Optimising Practice to Supportive Care that Enables Cure
por: Cornes, Paul, et al.
Publicado: (2020)

Recurrent Granulocyte Colony-Stimulating Factor-Induced Aortitis After Pegfilgrastim Administration
por: Kawahara, Hiroshi, et al.
Publicado: (2020)

Drug-induced aortitis of the subclavian artery caused by pegfilgrastim: a case report
por: Jimbo, Hikari, et al.
Publicado: (2021)

A Case of Concurrent Leukocytosis and Systemic Capillary Leak Syndrome Due to Pegfilgrastim
por: Gotera, Nico, et al.
Publicado: (2022)

Clinical Pharmacology of Antineoplastic Drugs
por: Stewart, A.
Publicado: (1979)

Antineoplastic activity of idazoxan hydrochloride
por: Eilon, G. F., et al.
Publicado: (2009)

Antineoplastic Effects of Honokiol on Melanoma
por: Guillermo-Lagae, Ruth, et al.
Publicado: (2017)

Promising Antineoplastic Actions of Melatonin
por: Favero, Gaia, et al.
Publicado: (2018)

Pulmonary Effects of Antineoplastic Therapy
por: Dhakal, Sughosh, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_7mafjrrsrohk7mic5n4bcnb8rd